The National Cancer Institute (NCI) is offering a grant to support exploratory research projects developing innovative technologies to enhance the quality of biospecimens used in cancer research. The focus is on addressing pre-analytical degradation issues during sample collection, processing, and storage. The grant aims to advance cancer biology, early detection, clinical diagnosis, and treatment by improving sample integrity and quality assessment. Applicants are encouraged to propose tools, devices, and methods that enhance research outcomes and reduce pre-analytical variations. This opportunity is part of NCI’s broader Innovative Molecular Analysis Technologies (IMAT) Program.
Opportunity ID: 289959
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-17-012 |
| Funding Opportunity Title: | Innovative Technologies for Cancer-Relevant Biospecimen Science (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | 5 |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 07, 2016 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 26, 2017 |
| Current Closing Date for Applications: | Sep 26, 2017 |
| Archive Date: | Oct 27, 2017 |
| Estimated Total Program Funding: | $1,200,000 |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) Small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments For profit organizations other than small businesses Private institutions of higher education Independent school districts Public and State controlled institutions of higher education State governments City or township governments Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) County governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies that improve the quality of the samples used for cancer research or clinical care. This includes new capabilities to address issues related to pre-analytical degradation of targeted analytes during the collection, processing, handling, and/or storage of cancer-relevant biospecimens. The overall goal is to support the development of highly innovative technologies capable of maximizing or otherwise interrogating the quality and utility of biological samples used for downstream analyses. This FOA will support the development of tools, devices, instrumentation, and associated methods to preserve or protect sample integrity, or establish verification criteria for quality assessment/quality control and handling under diverse conditions. These technologies are expected to accelerate and/or enhance research in cancer biology, early detection and screening, clinical diagnosis, treatment, epidemiology, or address issues associated with cancer health disparities, by reducing pre-analytical variations that affect biospecimen sample quality. This funding opportunity is part of a broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-17-012.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00229091 | Jan 28, 2017 | Sep 26, 2017 | View |
Package 1
Mandatory forms
289959 RR_SF424_2_0-2.0.pdf
289959 PHS398_CoverPageSupplement_3_0-3.0.pdf
289959 RR_OtherProjectInfo_1_3-1.3.pdf
289959 PerformanceSite_2_0-2.0.pdf
289959 RR_KeyPersonExpanded_2_0-2.0.pdf
289959 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
289959 RR_Budget_1_3-1.3.pdf
289959 RR_SubawardBudget30_1_3-1.3.pdf
289959 PHS398_ModularBudget_1_2-1.2.pdf
289959 PHS_Inclusion_Enrollment_Report-1.0.pdf
289959 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
